Thomas P. Mathers, Chief Executive Officer at CoLucid Pharmaceuticals, Inc. (CLCD), sold 3,004 shares at $38.75 ($116K) on 2016-12-05, disclosed to the SEC on 2016-12-05.
Open-market sale of $116k CLCD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.75 | 1,502 | $58K | 50.0% |
| 2 | $38.75 | 1,502 | $58K | 50.0% |
| Total | $38.75 avg | 3,004 | $116K | 100% |
| Filing → |
| CLCD | SELL | 2016-10-05 | $111K | — | Filing → |
| CLCD | SELL | 2016-09-16 | $140K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $201K | — | Filing → |